gemini-2.5-flash:<br><br>Recent news covers an analysis of Incyte's stock performance compared to other companies within the biotech sector. Concurrently, a Merck executive has expressed an unruffled attitude regarding the "unfortunate" leak of their cancer vaccine data ahead of the ESMO conference.<br><br>近期新闻涵盖了Incyte公司股价相对于其他生物科技公司表现的分析。同时，默克公司一位高管对其癌症疫苗数据在ESMO会议前不幸泄露一事表现出淡定的态度。<br><br><a href="https://hnsum.viigoo.eu.org/Incyte" target="_blank">https://hnsum.viigoo.eu.org/Incyte</a><br><a href="https://hnsum.viigoo.eu.org/StockPerformance" target="_blank">https://hnsum.viigoo.eu.org/StockPerformance</a><br><a href="https://hnsum.viigoo.eu.org/Biotech" target="_blank">https://hnsum.viigoo.eu.org/Biotech</a><br><a href="https://hnsum.viigoo.eu.org/Merck" target="_blank">https://hnsum.viigoo.eu.org/Merck</a><br><a href="https://hnsum.viigoo.eu.org/CancerVaccine" target="_blank">https://hnsum.viigoo.eu.org/CancerVaccine</a><br><a href="https://hnsum.viigoo.eu.org/DataLeak" target="_blank">https://hnsum.viigoo.eu.org/DataLeak</a><br><a href="https://hnsum.viigoo.eu.org/ESMO" target="_blank">https://hnsum.viigoo.eu.org/ESMO</a>